These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 23380305

  • 21. Deprivation of anticipated food under scheduled feeding induces c-Fos expression in the caudal part of the arcuate nucleus of hypothalamus through histamine H₁ receptors in rats: potential involvement of E3 subgroup of histaminergic neurons in tuberomammillary nucleus.
    Umehara H, Mizuguchi H, Mizukawa N, Matsumoto M, Takeda N, Senba E, Fukui H.
    Brain Res; 2011 Apr 28; 1387():61-70. PubMed ID: 21320473
    [Abstract] [Full Text] [Related]

  • 22. Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain.
    Laplante F, Morin Y, Quirion R, Vaucher E.
    Neuroscience; 2005 Apr 28; 132(2):501-10. PubMed ID: 15802200
    [Abstract] [Full Text] [Related]

  • 23. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD, Hradil V, Chin CL, Luo Y, Fox GB, McGaraughty S.
    Neuroscience; 2006 Apr 28; 137(2):583-91. PubMed ID: 16289887
    [Abstract] [Full Text] [Related]

  • 24. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
    Gbahou F, Davenas E, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):945-54. PubMed ID: 20530654
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND.
    Brain Res; 2008 Oct 09; 1234():16-24. PubMed ID: 18692487
    [Abstract] [Full Text] [Related]

  • 26. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
    Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Lianyi L, Wakiguchi H, Yokotani K.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):322-9. PubMed ID: 18423439
    [Abstract] [Full Text] [Related]

  • 27. Histamine in migraine and brain.
    Alstadhaug KB.
    Headache; 2014 Feb 10; 54(2):246-59. PubMed ID: 24433203
    [Abstract] [Full Text] [Related]

  • 28. Innervation of histamine neurons in the caudal part of the arcuate nucleus of hypothalamus and their activation in response to food deprivation under scheduled feeding.
    Umehara H, Mizuguchi H, Mizukawa N, Matsumoto M, Takeda N, Senba E, Fukui H.
    Methods Find Exp Clin Pharmacol; 2010 Dec 10; 32(10):733-6. PubMed ID: 21225009
    [Abstract] [Full Text] [Related]

  • 29. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats.
    Hong ZY, Huang ZL, Qu WM, Eguchi N, Urade Y, Hayaishi O.
    J Neurochem; 2005 Mar 10; 92(6):1542-9. PubMed ID: 15748171
    [Abstract] [Full Text] [Related]

  • 30. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
    Gao Z, Hurst WJ, Czechtizky W, Francon D, Griebel G, Nagorny R, Pichat P, Schwink L, Stengelin S, Hendrix JA, George PG.
    Bioorg Med Chem Lett; 2013 Nov 15; 23(22):6141-5. PubMed ID: 24076172
    [Abstract] [Full Text] [Related]

  • 31. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS.
    Biochem Pharmacol; 2007 Apr 15; 73(8):1157-71. PubMed ID: 17288995
    [Abstract] [Full Text] [Related]

  • 32. Effects of the histamine H3 receptor antagonist ABT-239 on acute and repeated nicotine locomotor responses in rats.
    Miszkiel J, Kruk M, McCreary AC, Przegaliński E, Biała G, Filip M.
    Pharmacol Rep; 2011 Apr 15; 63(6):1553-9. PubMed ID: 22358104
    [Abstract] [Full Text] [Related]

  • 33. Different Peas in the Same Pod: The Histaminergic Neuronal Heterogeneity.
    Provensi G, Passani MB, Blandina P.
    Curr Top Behav Neurosci; 2022 Apr 15; 59():303-327. PubMed ID: 34455575
    [Abstract] [Full Text] [Related]

  • 34. [Advances in the study of histaminergic systems and sleep-wake regulation].
    Liu TY, Hong ZY, Qu WM, Huang ZL.
    Yao Xue Xue Bao; 2011 Mar 15; 46(3):247-52. PubMed ID: 21626776
    [Abstract] [Full Text] [Related]

  • 35. Basal forebrain histaminergic transmission modulates electroencephalographic activity and emergence from isoflurane anesthesia.
    Luo T, Leung LS.
    Anesthesiology; 2009 Oct 15; 111(4):725-33. PubMed ID: 19741500
    [Abstract] [Full Text] [Related]

  • 36. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B, Gil-Bea FJ, Hirst WD, García-Alloza M, Ramírez MJ.
    Eur J Neurosci; 2006 Sep 15; 24(5):1299-306. PubMed ID: 16987217
    [Abstract] [Full Text] [Related]

  • 37. Histamine and schizophrenia.
    Arrang JM.
    Int Rev Neurobiol; 2007 Sep 15; 78():247-87. PubMed ID: 17349864
    [Abstract] [Full Text] [Related]

  • 38. Histaminergic ligands injected into the nucleus basalis magnocellularis differentially affect fear conditioning consolidation.
    Benetti F, Baldi E, Bucherelli C, Blandina P, Passani MB.
    Int J Neuropsychopharmacol; 2013 Apr 15; 16(3):575-82. PubMed ID: 22418001
    [Abstract] [Full Text] [Related]

  • 39. Histamine-immunoreactive neurons in the mouse and rat suprachiasmatic nucleus.
    Michelsen KA, Lozada A, Kaslin J, Karlstedt K, Kukko-Lukjanov TK, Holopainen I, Ohtsu H, Panula P.
    Eur J Neurosci; 2005 Oct 15; 22(8):1997-2004. PubMed ID: 16262638
    [Abstract] [Full Text] [Related]

  • 40. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z, Ichikawa J, Dai J, Meltzer HY.
    Eur J Pharmacol; 2004 Jun 16; 493(1-3):75-83. PubMed ID: 15189766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.